| 1. Gege Li#, Jiashuai Xu, Xiaohan Tian, Jingyi Xiao, Junqi Long, Yining Chen, Wenzhi Shen*, Shuangtao Zhao*.Comment on intra-patient variation in PD-L1 expression and tumor mutational burden and the impact on outcomes to immune checkpoint inhibitor therapy in patients with non-small-cell lung cancer.Journal for ImmunoTherapy of Cancer.2026.--. .SCI(含SCIE) |